Bacteriophage Therapy for Orthopedic Implant-Associated Infections

Starting soon · Phase 3

Conditions studied: Orthopedic, Implant Infection

In brief

A Prospective, Single-Center, Single-Arm Clinical Study with a Pre-Post Self-Controlled Design Evaluating the Efficacy and Safety of Bacteriophage Therapy for Refractory Orthopedic Implant-Associated Infections

Key facts

Study ID

NCT07533292

Run by

Second Affiliated Hospital, Zhejiang University, School of Medicine

People needed

100

Starts

2026-04-05

Expected to finish

2030-12-31

Last updated by the study team

2026-04-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Known allergy or hypersensitivity to bacteriophages or any components of the bacteriophage preparation;
• Pregnant or breastfeeding women;
• Participation in another interventional clinical trial within the study period;
• Lack of feasible routes of administration other than intravenous injection;
• Patients deemed unsuitable for participation in this study by the investigator;
• Inability or unwillingness of the subject to comply with study procedures.

You may not qualify if…

• Withdrawal of informed consent by the participant at any time during the study;
• Occurrence of serious adverse events related to bacteriophage therapy that, in the investigator's judgment, necessitate discontinuation of treatment.

Where it is running

• the Second Affiliated Hospital of Zhejiang University School of Medicine — Hangzhou, Zhejiang, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.